超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

美國Inspire Pharmaceuticals
Inspire Pharmaceuticals 與Allergan 合作研究的眼干燥癥治療藥物Diquafosol Tet rasodium(二尿嘧啶核苷四聚磷酸酯四鈉鹽) ,也已經在美國提出新藥申請(注冊) 。
Inspire is a biopharmaceutical company focused on researching, developing, and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Our goal is to build and commercialize a sustainable portfolio of innovative new products based on our technical and scientific expertise. The most advanced compounds in our clinical pipeline are PROLACRIATM for dry eye and denufosol tetrasodium for cystic fibrosis, which are both in Phase 3 development and AZASITE? for blepharitis, which is in Phase 2 development. We receive revenue related to the promotion of AZASITE for bacterial conjunctivitis, co-promotion of ELESTAT? for allergic conjunctivitis and royalties on RESTASIS? for dry eye.